Myeloma Minute: New Cancer Drug Considerations

Cancer Patients with Unmet Needs Fuel the Push for New Drugs, New Considerations

In the aggressive fight to stop cancer, “we need to adjust our expectations for new drug development and testing,” says IMF Chairman Dr. Brian Durie. “Single agents (preferably) or combinations must not only produce remissions, but those deep and sustained remissions must be achieved with acceptable toxicities and costs.” Also, the University of California launches a new cancer consortium, and a case of medical tourism to China. Read Dr. Durie's blog.

Summer Edition of Myeloma Today: IMWG 2017 and ASCO 2017 Highlights and More

The latest issue of Myeloma Today is out with news on the 2017 International Myeloma Working Summit, on ASCO 2017, on the Global Myeloma Advocacy Network, and on the state of US health-care policy. For a dose of inspiration, read myeloma patient René Hicks’s story, “A Tale of Two Cancers.” René, who is also a stand-up comedian, views her myeloma journey.

Register NOW for the IMF Patient & Family Seminar in Dallas, Texas for FREE!

An IMF Patient and Family Seminar will take place during the weekend of October 6th and 7th, 2017 at The Westin Galleria in Dallas, Texas (13340 Dallas Parkway). You may register for one or both days of the event. The expert speakers include Dr. Brian Durie (Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute), Dr. Rafat Abonour (Indiana University School of Medicine), Dr. Craig Cole (Michigan University Cancer Center), Dr. Larry Anderson (UT Southwestern Medical Center) and Dr. Saad Usmani (Levine Cancer Institute).

Reports from 2017 Summits of IMWG and GMAN Now Available in Multiple Languages

The Summer 2017 edition of the IMF’s Myeloma Messenger, a compendium of selected articles from the IMF’s quarterly journal Myeloma Today, is now available in FrenchGermanItalian, and Spanish. Highlights include overviews of the 2017 Summits of the International Myeloma Working Group (IMWG) and the Global Myeloma Action Network (GMAN), as well as the 2017 annual meeting of the American Society of Clinical Oncology (ASCO). View all IMF translations.

Firefighters and Myeloma Risk: U.S. Bill Introduced to Research Cancer Incidence

Firefighters put their lives on the line by charging into burning buildings and rescuing people from dangerous situations. Sadly, the elements firefighters are exposed to while performing their heroic work may cause cancers, like multiple myeloma. On September 12, 2017, the House of Representatives passed H.R. 931, the Firefighter Cancer Registry Act of 2017. If signed into law, the bill will create a voluntary national registry to collect information, so researchers can better understand cancer incidence in firefighters. View this legislation. 

The Third Annual Walk-A-Thon to End Multiple Myeloma in Queens, NY

On Sunday, September 24th, the Third Annual Walk-A-Thon to End Multiple Myeloma takes place in Flushing Meadows Park in Queens, New York, from 8:00 a.m. to 2:00 p.m. ET. Organized by myeloma patient Theresa Tucker and her friend Shelia Burton, this year’s race supporters are invited to a small barbecue afterwards in the park. Also, Theresa welcomes and honors fellow patient Susan Thompson. Theresa has this hope: “With your support, we can raise even more money towards research in the prevention, treatment, and cure of multiple myeloma.”

Can I adjust my dexamethasone dosing to once a day?

In this week’s video, Dr. Brian GM Durie explains that even if dex gives you a boost, you should not take it daily.

 

 


We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Pharmaceuticals, and Takeda Oncology

 

 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.